Immunological aspects in late phase of living donor liver transplant patients: Usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Mizuno, Shugo ^a   Muraki, Yuichi ^a   Nakatani, Kaname ^a   Tanemura, Akihiro ^a   Kuriyama, Naohisa ^a   Ohsawa, Ichiro ^a   Azumi, Yoshinori ^a   Kishiwada, Masashi ^a   Usui, Masanobu ^a   Sakurai, Hiroyuki ^a   Tabata, Masami ^a   Yamamoto, Norihiko ^a   Yamada, Tomomi ^a   Shiraki, Katsuya ^a   Takei, Yoshiyuki ^a   Nobori, Tsutomu ^a   Okuda, Masahiro ^a   Isaji, Shuji ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME P450 3A5; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; CYP3A5 PROTEIN, HUMAN; CYTOCHROME P450 3A; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CHOLANGITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HUMAN; IMMUNOKNOW ASSAY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; PHLEGMON; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZATION; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTION; BLOOD; GENETICS; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; INFECTION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CYTOCHROME P-450 CYP3A; FEMALE; GENOTYPE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TACROLIMUS; TRANSPLANTATION IMMUNOLOGY; YOUNG ADULT;

EID: 84885618370     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/982163     Document Type: Article

References (24)

1. Brick C., Atouf O., Benseffaj N., Essakalli M., Rejection of kidney graft: mechanism and prevention. Nephrologie et Therapeutique 2011 7 1 18 26 2-s2.0-79751514439 10.1016/j.nephro.2010.10.002
2. Grulich A. E., van Leeuwen M. T., Falster M. O., Vajdic C. M., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. The Lancet 2007 370 9581 59 67 2-s2.0-34347323902 10.1016/S0140-6736(07)61050-2 (Pubitemid 47017468)
3. Shapiro R., End-stage renal disease in 2010: innovative approaches to improve outcomes in transplantation. Nature Reviews Nephrology 2011 7 2 68 70 2-s2.0-79551567119 10.1038/nrneph.2010.179
4. Venkataramanan R., Shaw L. M., Sarkozi L., Mullins R., Pirsch J., MacFarlane G., Scheller D., Ersfeld D., Frick M., Fitzsimmons W. E., Virji M., Jain A., Brayman K. L., Shaked A., Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. Journal of Clinical Pharmacology 2001 41 5 542 551 2-s2.0-17744394054 10.1177/00912700122010429 (Pubitemid 32381872)
5. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, KDIGO clinical practice guideline for the care of kidney transplant recipients. American Journal of Transplantation 2009 9 supplement 3 S1 S155
6. Kowalski R., Post D., Schneider M. C., Britz J., Thomas J., Deierhoi M., Lobashevsky A., Redfield R., Schweitzer E., Heredia A., Reardon E., Davis C., Bentlejewski C., Fung J., Shapiro R., Zeevi A., Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clinical Transplantation 2003 17 2 77 88 2-s2.0-0037626590 10.1034/j.1399-0012. 2003.00013.x (Pubitemid 36833776)
7. Mizuno S., Hamada T., Nakatani K., Kishiwada M., Usui M., Sakurai H., Tabata M., Sakamoto Y., Nishioka J., Muraki Y., Okuda M., Nobori T., Isaji S., Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype. Journal of Hepato-Biliary-Pancreatic Sciences 2011 18 2 226 234 2-s2.0-79959856088 10.1007/s00534-010-0335-8
8. Kowalski R. J., Post D. R., Mannon R. B., Sebastian A., Wright H. I., Sigle G., Burdick J., Elmagd K. A., Zeevi A., Lopez-Cepero M., Daller J. A., Gritsch H. A., Reed E. F., Jonsson J., Hawkins D., Britz J. A., Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006 82 5 663 668 2-s2.0-33748690103 10.1097/01.tp.0000234837.02126.70 (Pubitemid 44395237)
9. Israeli M., Yussim A., Mor E., Sredni B., Klein T., Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform. Transplant Immunology 2007 18 1 7 12 2-s2.0-34250328218 10.1016/j.trim.2007.03.005 (Pubitemid 46920968)
10. Berglund D., Bengtsson M., Biglarnia A., Berglund E., Yamamoto S., von Zur-Mühlen B., Lorant T., Tufveson G., Screening of mortality in transplant patients using an assay for immune function. Transplant Immunology 2011 24 4 246 250 2-s2.0-79955472274 10.1016/j.trim.2010.12.005
11. Demetris A. J., Batts K. P., Dhillon A. P., Ferrell L., Fung J., Geller S. A., Hart J., Hayry P., Hofmann W. J., Hubscher S., Kemnitz J., Koukoulis G., Lee R. G., Lewin K. J., Ludwig J., Markin R. S., Petrovic L. M., James Phillips M., Portmann B., Rakela J., Randhawa P., Reinholt F. P., Reynés M., Robert M., Schlitt H., Solez K., Snover D., Taskinen E., Thung S. N., Weldon Tillery G., Wiesner R. H., Derek Wight D. G., Williams J. W., Yamabe H., Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997 25 3 658 663 2-s2.0-0031052357 10.1002/hep.510250328 (Pubitemid 27106450)
12. Shiraga T., Matsuda H., Nagase K., Iwasaki K., Noda K., Yamazaki H., Shimada T., Funae Y., Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. Biochemical Pharmacology 1994 47 4 727 735 2-s2.0-0028295725 10.1016/0006-2952(94)90136-8 (Pubitemid 24094278)
13. Neuberger J., Liver transplantation. Journal of Hepatology 2000 32 1 198 207 2-s2.0-0034048670 (Pubitemid 30123635)
14. Rodrigo E., López-Hoyos M., Corral M., Fábrega E., Fernández-Fresnedo G., San Segundo D., Piñera C., Arias M., ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis. Liver Transplantation 2012 18 10 1245 1253
15. Ling X., Xiong J., Liang W., Schroder P. M., Wu L., Ju W., Kong Y., Shang Y., Guo Z., He X., Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis. Transplantation 2012 93 7 737 743 2-s2.0-84859265562 10.1097/TP.0b013e3182466248
16. Berenguer M., Prieto M., Córdoba J., Rayón J. M., Carrasco D., Olaso V., San-Juan F., Gobernado M., Mir J., Berenguer J., Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. Journal of Hepatology 1998 28 5 756 763 2-s2.0-0032080213 10.1016/S0168-8278(98)80224-9 (Pubitemid 28223478)
17. Everson G. T., Impact of immunosuppresive therapy on recurrence of hepatitis C. Liver Transplantation 2002 8 10 S19 S27 2-s2.0-0036795626 10.1053/jlts.2002.35852 (Pubitemid 35154039)
18. Lake J. R., The role of immunosuppression in recurrence of hepatitis C. Liver Transplantation 2003 9 11 S63 S66 2-s2.0-0242624528 10.1053/jlts.2003. 50264 (Pubitemid 37408006)
19. Neumann U. P., Berg T., Bahra M., Seehofer D., Langrehr J. M., Neuhaus R., Radke C., Neuhaus P., Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. Journal of Hepatology 2004 41 5 830 836 2-s2.0-7244247475 10.1016/j.jhep.2004.06.029 (Pubitemid 39434314)
20. Yilmaz N., Shiffman M. L., Stravitz R. T., Sterling R. K., Luketic V. A., Sanyal A. J., Mills A. S., Contos M. J., Coterell A., Maluf D., Posner M. P., Fisher R. A., A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transplantation 2007 13 7 975 983 2-s2.0-34547455714 10.1002/lt.21117 (Pubitemid 47163189)
21. Mendler M., Kwok H., Franco E., Baron P., Weissman J., Ojogho O., Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity. Liver Transplantation 2008 14 9 1313 1322 2-s2.0-51549116306 10.1002/lt.21529
22. Hashimoto K., Miller C., Hirose K., Diago T., Aucejo F., Quintini C., Eghtesad B., Corey R., Yerian L., Lopez R., Zein N., Fung J., Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clinical Transplantation 2010 24 5 701 708 2-s2.0-78650478180 10.1111/j.1399-0012.2009.01169.x
23. Alkhouri N., Hanouneh I. A., Lopez R., Zein N. N., Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression. Liver Transplantation 2010 16 2 155 162 2-s2.0-75449084723 10.1002/lt.21939
24. Fukudo M., Yano I., Yoshimura A., Masuda S., Uesugi M., Hosohata K., Katsura T., Ogura Y., Oike F., Takada Y., Uemoto S., Inui K.-I., Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenetics and Genomics 2008 18 5 413 423 2-s2.0-42149176588 10.1097/FPC.0b013e3282f9ac01 (Pubitemid 351535942)